The GLP-1 Revolution: What Fortune 500 Employers Need to Know
GLP-1 drugs are reshaping employer healthcare economics. Learn how leading organizations are managing costs while supporting clinical outcomes.
Evidence-based perspectives on PBM strategy, GLP-1 management, and employer healthcare intelligence
GLP-1 drugs are reshaping employer healthcare economics. Learn how leading organizations are managing costs while supporting clinical outcomes.
Hidden spread pricing, rebate games, and contract distortions cost employers millions. Here's how to audit your PBM relationship.
Healthcare is one of the largest operating expenses for Fortune 500 companies. Why aren't CFOs treating it like capital allocation?
Every number should come with receipts. How Kincaid IQ brings audit-grade transparency to employer healthcare spend.
Hidden compensation, conflicted incentives, performance gaps — how to evaluate your benefits broker objectively.
Most AI in benefits is marketing theater. Here's what evidence-based AI actually looks like for employer intelligence.
Get monthly insights on PBM strategy, GLP-1 trends, and healthcare intelligence delivered to your inbox.
We respect your inbox. No spam, ever. Unsubscribe anytime.